Cargando…
Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.
The optimal drug-light interval for effective photodynamic therapy (PDT) of early squamous cell carcinomas was evaluated with tetra(m-hydroxyphenyl)chlorin (mTHPC) by means of two complementary modalities: irradiation tests and ex vivo fluorescence microscopy. A Syrian hamster cheek pouch tumour mod...
Autores principales: | Andrejevic-Blant, S., Hadjur, C., Ballini, J. P., Wagnières, G., Fontolliet, C., van den Bergh, H., Monnier, P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228103/ https://www.ncbi.nlm.nih.gov/pubmed/9376261 |
Ejemplares similares
-
Uptake and localisation of mTHPC (Foscan®) and its(14)C-labelled form in normal and tumour tissues of the hamster squamous cell carcinoma model: a comparative study
por: Blant, S Andrejevic, et al.
Publicado: (2002) -
Synergistic effect of meta-tetra(hydroxyphenyl)chlorin-based photodynamic therapy followed by cisplatin on malignant Hep-2 cells
por: Xue, Kai, et al.
Publicado: (2019) -
Second primary squamous cell carcinoma arising in cutaneous flap reconstructions of two head and neck cancer patients
por: Monnier, Yan, et al.
Publicado: (2007) -
Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II.
por: Grosjean, P., et al.
Publicado: (1998) -
Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model
por: Rovers, J P, et al.
Publicado: (1999)